Table 2.

Mutations detected by TST15 tumor panel sequencing


NGS True Sight
15 Tumor
(TST 15)
Panel
Index Polyps


Secondary Lesions
Without Secondary LesionsaWith Secondary Lesionsb
No mutations found798
Mutations found356
Total (% with mutations)10 (30%)14 (36%)14 (43%)
  • a Mutations in polyps without secondary lesions: BRAF (n = 1) and TP53 (n = 2).

  • b Mutations in polyps with secondary lesions: BRAF (n = 1), KRAS (n = 1), and TP53 (n = 3).